GGrantIndex
Sort

261,768 grants matching gene therapy

Novel Strategies to Improve Blood Transfusion Practice

$2,590,165
Hongbo R Luo · Boston Children'S Hospital · P01 · FY2023 · HL

Genes And Gene Products As Immunoadjuvants

$2,589,919
Steven M Holland · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)

$2,589,347
Linmarie Sikich · Univ Of North Carolina Chapel Hill · U01 · FY2012 · HD

Attacking failure of antibiotic treatment by targeting antimicrobial resistance enabler cell-states

$2,588,682
Tim Van Opijnen · Boston Children'S Hospital · U19 · FY2024 · AI

DNA Sequencing and FACS Core Facilities

$2,587,962
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

SPORE IN LUNG CANCER

$2,586,702
University Of Colorado Denver · P50 · FY2001 · CA

Host Pathogen Variation & TB Pathogenesis

$2,586,191
Thomas R Hawn · University Of Washington · U19 · FY2022 · AI

Genetics and therapies of retinal diseases

$2,586,039
Anand Swaroop · National Eye Institute · Z01 · FY2008 · EY

The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center

$2,585,894
Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA

Targeted Bone Regeneration via Activation of Resident Stem Cells

$2,585,805
Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR

Novel Therapies for Muco-Obstructive Lung Diseases

$2,585,676
Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2015 · HL

DF/HCC Prostate SPORE

$2,585,567
Himisha Beltran · Dana-Farber Cancer Inst · P50 · FY2023 · CA

Mechanisms of sleep and sleep apnea

$2,585,120
Clifford B Saper · Beth Israel Deaconess Medical Center · P01 · FY2024 · HL

Pharmacogenomics and Risk of Cardiovascular Disease

$2,584,979
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U19 · FY2012 · HL

Transplant Tolerance in Non-Human Primates

$2,584,553
Christian P Larsen · Emory University · U19 · FY2017 · AI

Spore in Head and Neck Cancer

$2,583,916
David Sidransky · Johns Hopkins University · P50 · FY2011 · DE

Host Pathogen Variation & TB Pathogenesis

$2,583,647
Thomas R Hawn · University Of Washington · U19 · FY2024 · AI

Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment

$2,583,394
Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC

Determinants of TB control, relapse and reinfection

$2,583,322
Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2022 · AI

Mechanisms and Therapy of Chronic Graft-vs.-Host Disease

$2,583,098
Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2023 · HL

Determinants of TB control, relapse and reinfection

$2,583,036
Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2024 · AI

T Cell Costimulatory Pathways: Functions and Interactions

$2,582,651
Arlene H Sharpe · Harvard Medical School · P01 · FY2019 · AI

Transforming Human Pancreatic Cancer Into An Immunologic Disease

$2,582,338
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2021 · CA

Transforming Human Pancreatic Cancer Into An Immunologic Disease

$2,582,338
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2025 · CA

Route 66 Endometrial Cancer SPORE

$2,581,832
David G Mutch · Washington University · P50 · FY2025 · CA